BioInvent International AB (0H22) Share Forecast & Price Target
0H22 Analyst Ratings
There are no analyst ratings in the last 3 months.
0H22 Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Oscar Haffen Lamm | Stifel Nicolaus | SEK 90 | buy | 1566.67%Upside | Reiterated | 05/22/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Oscar Haffen Lamm | 05/22/26 | SEK 90 | buy | 1566.67%Upside | Reiterated | Stifel Nicolaus |
Best Analysts Covering BioInvent International AB
Copying Oscar Haffen Lamm's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
Copying Oscar Haffen Lamm's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -40.70% per trade.
Copying Oscar Haffen Lamm's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -81.40% per trade.
0H22 Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 1 | 1 | 0 | 0 | 0 |
In the current month, 0H22 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0H22 average Analyst price target in the past 3 months is ―.
0H22 Financial Forecast
0H22 Earnings Forecast
Next quarter’s earnings estimate for 0H22 is -SEK 1.81 with a range of ― to ―. The previous quarter’s EPS was -SEK 1.81. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
0H22 Sales Forecast
Next quarter’s sales forecast for 0H22 is SEK 10.79M with a range of ― to ―. The previous quarter’s sales results were SEK 10.79M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
